Cell and Gene Therapy Biomanufacturing Market Research Report Information By Product Type (Consumables, Equipment and Software Solutions), By Usage (Commercial Stage Manufacturing and Research Stage Manufacturing), By Application (Upstream Processing, Harvesting and Downstream Processing), By End User (Life Science Companies, Contract Research Organizations, Contract Manufacturing Organizations and Cell Banks) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032
Market Overview
In 2022, the cell and gene therapy biomanufacturing market was valued at USD 12.6 billion. The Cell and Gene Therapy Biomanufacturing market is expected to increase from USD 13.9 billion in 2023 to USD 31.2 billion by 2032, with a compound yearly growth rate (CAGR) of 10.60% over the forecast period (2024-2032). Growing investments in cell and gene therapy research are significant industry drivers, accelerating market expansion.
The rapid growth of the Cell and Gene Therapy Market drives the Cell and Gene Therapy Biomanufacturing Market forward by increasing demand for manufacturing solutions. With the approval of novel cell and gene therapies and encouraging clinical trial findings, there is a growing need to increase manufacturing to satisfy commercialization demands. The market's exponential growth needs the development of efficient, scalable, and cost-effective biomanufacturing processes and infrastructure. To meet the increased demand for cell and gene therapy products, biomanufacturing businesses are investing in advanced technologies like automation, single-use systems, and closed-system bioreactors. Furthermore, market expansion is driving collaborations, partnerships, and investments in biomanufacturing capacity, which is supporting growth in the Cell and Gene Therapy Biomanufacturing Market to address the needs of the continuously changing cell and gene therapy environment.
Market Segment insights
Consumables, Equipment, and Software Solutions make up the Product Type division of the Cell and Gene Therapy Biomanufacturing Market.
Usage-based market segmentation includes Commercial Stage Manufacturing and Research Stage Manufacturing.
The market is segmented by application, which comprises upstream processing, harvesting, and downstream processing.
Life Science Companies, Contract Research Organizations, Contract Manufacturing Organizations, and Cell Banks are the end-user segments of the Cell and Gene Therapy Biomanufacturing Market.
Regional insights
The analysis covers market insights for North America, Europe, Asia-Pacific, and the rest of the world. Several reasons have contributed to North America's dominance in the Cell and Gene Therapy Biomanufacturing Market. To begin with, the region has a strong ecosystem of biotechnology and pharmaceutical businesses that are actively involved in cell and gene therapy research and development. Second, North America has well-established regulatory frameworks and supporting policies for cell and gene therapy manufacturing, which helps the market flourish.
Because of its qualified workforce, Europe has the second-largest market share in cell and gene therapy biomanufacturing. Europe has the second-largest market share in the Cell and Gene Therapy Biomanufacturing Market due to a variety of factors. The region has a well-established biopharmaceutical industry, modern infrastructure, and a competent workforce.
The Asia-Pacific Cell and Gene Therapy Biomanufacturing Market is predicted to expand at the quickest CAGR between 2024 and 2032. The Asia Pacific region has the greatest compound annual growth rate (CAGR) in the Cell and Gene Therapy Biomanufacturing Market due to a variety of factors. To begin, the region's fast expanding biopharmaceutical industry is being pushed by increased investment in R&D, particularly in cell and gene therapy.
Major Players
The Cell and Gene Therapy Biomanufacturing market is dominated by Lonza Group, Thermo Fisher Scientific Inc., Merck KGaA, WuXi AppTec, Catalent, Inc., Samsung Biologics, FUJIFILM Diosynth Biotechnologies, Charles River Laboratories, Cytiva, Novasep, and others.
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 GLOBAL CELL AND GENE THERAPY BIOMANUFACTURING MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL CELL AND GENE THERAPY BIOMANUFACTURING MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY USAGE, 2019-2032 (USD BILLION)
TABLE 5 GLOBAL CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 6 GLOBAL CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY USAGE, 2019-2032 (USD BILLION)
TABLE 9 NORTH AMERICA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 10 NORTH AMERICA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 11 US: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 12 US: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY USAGE, 2019-2032 (USD BILLION)
TABLE 13 US: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 14 US: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 15 CANADA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 16 CANADA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY USAGE, 2019-2032 (USD BILLION)
TABLE 17 CANADA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 18 CANADA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 19 EUROPE: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 20 EUROPE: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY USAGE, 2019-2032 (USD BILLION)
TABLE 21 EUROPE: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 22 EUROPE: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 23 GERMANY: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 24 GERMANY: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY USAGE, 2019-2032 (USD BILLION)
TABLE 25 GERMANY: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 26 GERMANY: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 27 FRANCE: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 28 FRANCE: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY USAGE, 2019-2032 (USD BILLION)
TABLE 29 FRANCE: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 30 FRANCE: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 31 ITALY: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 32 ITALY: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY USAGE, 2019-2032 (USD BILLION)
TABLE 33 ITALY: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 34 ITALY: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 35 SPAIN: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 36 SPAIN: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY USAGE, 2019-2032 (USD BILLION)
TABLE 37 SPAIN: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 38 SPAIN: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 39 UK: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 40 UK: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY USAGE, 2019-2032 (USD BILLION)
TABLE 41 UK: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 42 UK: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 43 REST OF EUROPE: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 44 REST OF EUROPE: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY USAGE, 2019-2032 (USD BILLION)
TABLE 45 REST OF EUROPE: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 46 REST OF EUROPE: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 47 ASIA-PACIFIC: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 48 ASIA-PACIFIC: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY USAGE, 2019-2032 (USD BILLION)
TABLE 49 ASIA-PACIFIC: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 50 ASIA-PACIFIC: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 51 JAPAN: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 52 JAPAN: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY USAGE, 2019-2032 (USD BILLION)
TABLE 53 JAPAN: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 54 JAPAN: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 55 CHINA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 56 CHINA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY USAGE, 2019-2032 (USD BILLION)
TABLE 57 CHINA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 58 CHINA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 59 INDIA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 60 INDIA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY USAGE, 2019-2032 (USD BILLION)
TABLE 61 INDIA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 62 INDIA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 63 AUSTRALIA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 64 AUSTRALIA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY USAGE, 2019-2032 (USD BILLION)
TABLE 65 AUSTRALIA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 66 AUSTRALIA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 67 SOUTH KOREA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 68 SOUTH KOREA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY USAGE, 2019-2032 (USD BILLION)
TABLE 69 SOUTH KOREA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 70 SOUTH KOREA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 71 REST OF ASIA-PACIFIC: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 72 REST OF ASIA-PACIFIC: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY USAGE, 2019-2032 (USD BILLION)
TABLE 73 REST OF ASIA-PACIFIC: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 74 REST OF ASIA-PACIFIC: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 75 REST OF THE WORLD: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 76 REST OF THE WORLD: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY USAGE, 2019-2032 (USD BILLION)
TABLE 77 REST OF THE WORLD: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 78 REST OF THE WORLD: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 79 MIDDLE EAST: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 80 MIDDLE EAST: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY USAGE, 2019-2032 (USD BILLION)
TABLE 81 MIDDLE EAST: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 82 MIDDLE EAST: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 83 AFRICA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 84 AFRICA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY USAGE, 2019-2032 (USD BILLION)
TABLE 85 AFRICA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 86 AFRICA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY END USER, 2019-2032 (USD BILLION)
TABLE 87 LATIN AMERICA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY PRODUCT TYPE, 2019-2032 (USD BILLION)
TABLE 88 LATIN AMERICA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY USAGE, 2019-2032 (USD BILLION)
TABLE 89 LATIN AMERICA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY APPLICATION, 2019-2032 (USD BILLION)
TABLE 90 LATIN AMERICA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, BY END USER, 2019-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL CELL AND GENE THERAPY BIOMANUFACTURING MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL CELL AND GENE THERAPY BIOMANUFACTURING MARKET
FIGURE 4 GLOBAL CELL AND GENE THERAPY BIOMANUFACTURING MARKET, SHARE (%), BY PRODUCT TYPE, 2023
FIGURE 5 GLOBAL CELL AND GENE THERAPY BIOMANUFACTURING MARKET, SHARE (%), BY USAGE, 2023
FIGURE 6 GLOBAL CELL AND GENE THERAPY BIOMANUFACTURING MARKET, SHARE (%), BY APPLICATION, 2023
FIGURE 7 GLOBAL CELL AND GENE THERAPY BIOMANUFACTURING MARKET, SHARE (%), BY END USER, 2023
FIGURE 8 GLOBAL CELL AND GENE THERAPY BIOMANUFACTURING MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 NORTH AMERICA: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 EUROPE: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 ASIA-PACIFIC: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, SHARE (%), BY REGION, 2023
FIGURE 12 REST OF THE WORLD: CELL AND GENE THERAPY BIOMANUFACTURING MARKET, SHARE (%), BY REGION, 2023
FIGURE 13 GLOBAL CELL AND GENE THERAPY BIOMANUFACTURING MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 14 LONZA GROUP: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 LONZA GROUP: SWOT ANALYSIS
FIGURE 16 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS
FIGURE 18 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 MERCK KGAA: SWOT ANALYSIS
FIGURE 20 WUXI APPTEC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 WUXI APPTEC: SWOT ANALYSIS
FIGURE 22 CATALENT, INC..: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 CATALENT, INC..: SWOT ANALYSIS
FIGURE 24 SAMSUNG BIOLOGICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 SAMSUNG BIOLOGICS: SWOT ANALYSIS
FIGURE 26 FUJIFILM DIOSYNTH BIOTECHNOLOGIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 FUJIFILM DIOSYNTH BIOTECHNOLOGIES: SWOT ANALYSIS
FIGURE 28 CHARLES RIVER LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 CHARLES RIVER LABORATORIES: SWOT ANALYSIS
FIGURE 30 CYTIVA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 CYTIVA: SWOT ANALYSIS
FIGURE 32 NOVASEP: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 NOVASEP: SWOT ANALYSIS
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們